From Casetext: Smarter Legal Research

Boustead Sec. v. G Med. Innovations Holdings

United States District Court, S.D. New York
Oct 20, 2022
1:22-cv-4618-MKV (S.D.N.Y. Oct. 20, 2022)

Opinion

1:22-cv-4618-MKV

10-20-2022

BOUSTEAD SECURITIES, LLC Plaintiff, v. G MEDICAL INNOVATIONS HOLDINGS LTD. and G MEDICAL INNOVATIONS USA INC., Defendants.


ORDER OF DISMISSAL

MARY KAY VYSKOCIL, United States District Judge.

The Court is in receipt of a letter filed by Defendant informing the Court that the parties have reached a settlement in principle. [ECF No. 43.] Accordingly, IT IS HEREBY ORDERED that the above-captioned action is discontinued without costs to any party and without prejudice to restoring the action to this Court's calendar if the parties are unable to memorialize their settlement in writing and as long as the application to restore the action is made by November 20, 2022. If no such application is made by that date, today's dismissal of the action is with prejudice. See Muze, Inc. v. Digital On Demand, Inc., 356 F.3d 492, 494 n.1 (2d Cir. 2004).

SO ORDERED.


Summaries of

Boustead Sec. v. G Med. Innovations Holdings

United States District Court, S.D. New York
Oct 20, 2022
1:22-cv-4618-MKV (S.D.N.Y. Oct. 20, 2022)
Case details for

Boustead Sec. v. G Med. Innovations Holdings

Case Details

Full title:BOUSTEAD SECURITIES, LLC Plaintiff, v. G MEDICAL INNOVATIONS HOLDINGS LTD…

Court:United States District Court, S.D. New York

Date published: Oct 20, 2022

Citations

1:22-cv-4618-MKV (S.D.N.Y. Oct. 20, 2022)